Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
9 pending office actions • 8 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Shanghaitech University currently manages 10 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 10 distinct examiners, which matches the total count of pending office actions. This distribution suggests that the university's patent strategy involves diverse subject matter or highly specialized filings that do not cluster under a single primary reviewer at this time.
The portfolio spans 9 distinct art units, which is nearly equal to the total number of 10 pending office actions. This breadth across art units reinforces the observation of a diverse technical scope within the biotechnology sector. SPENCER, ANDREA LYNNE MORRIS is identified as the busiest examiner for this portfolio, though they are responsible for only 1 busiest examiner pending action. Practitioners should prepare for varied examination styles given that 10 different examiners are currently reviewing the university's applications. This lack of examiner concentration may require more individualized strategies for each application rather than a unified approach across the portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (11%) |
| §103 only | 1 (11%) |
| §112 only | 2 (22%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 4 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPENCER, ANDREA LYNNE MORRIS | 1 | 22.2% | +35.7% |
| ENGLISH, CONNOR KENNEDY | 1 | 60.0% | +51.3% |
| ISLAM, PROMOTTO TAJRIAN | 1 | 77.4% | +13.8% |
| ZENG, WENWEI | 1 | — | — |
| KAUFMAN, CLAIRE M | 1 | 63.5% | +50.7% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.0% | +18.0% |
| UNDERDAHL, THANE E | 1 | 58.8% | +50.8% |
| KONOPKA, CATHERINE ANNE | 1 | 58.1% | +65.0% |
| AGUIRRE, AMANDA L | 1 | 77.2% | +15.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18067732 | Decontamination of Environmental Water Sources Using Living Engineered Biofilm Materials | UNDERDAHL, THANE E | 30d |
| 18840525 | NUCLEIC ACID CONSTRUCT BASED ON CRE-LOXP AND CRISPR AND USE THEREOF | SPENCER, ANDREA LYNNE MORRIS | — |
| 18387463 | HIGH-EFFICIENT QUANTIZATION METHOD FOR DEEP PROBABILISTIC NETWORK | ZENG, WENWEI | — |
| 18557232 | INTRAMUSCULAR COMPOSITIONS OF BOTULINUM NEUROTOXINS | KAUFMAN, CLAIRE M | — |
| 17801689 | APPLICATION OF DISULFIRAM IN CORONAVIRUS RESISTANCE | AGUIRRE, AMANDA L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18067732 | Decontamination of Environmental Water Sources Using Living Engineered Biofilm Materials | UNDERDAHL, THANE E | 30d |
| 18418386 | NEURAL IMPLICIT FUNCTION FOR END-TO-END RECONSTRUCTION OF DYNAMIC CRYO-EM STRUCTURES | ISLAM, PROMOTTO TAJRIAN | 35d |
| 18840525 | NUCLEIC ACID CONSTRUCT BASED ON CRE-LOXP AND CRISPR AND USE THEREOF | SPENCER, ANDREA LYNNE MORRIS | — |
| 18689031 | PROTEIN DEGRADATION COMPOUND BASED ON NAMPT TARGET PROTEIN AND APPLICATION THEREOF | ENGLISH, CONNOR KENNEDY | — |
| 18557232 | INTRAMUSCULAR COMPOSITIONS OF BOTULINUM NEUROTOXINS | KAUFMAN, CLAIRE M | — |
| 18553729 | GENE THERAPY FOR TREATING BETA-HEMOGLOBINOPATHIES | POLIAKOVA-GEORGAN, EKATERINA | — |
| 17822418 | COMPOSITIONS AND METHODS FOR DETECTING NUCLEIC ACID-PROTEIN INTERACTIONS | KONOPKA, CATHERINE ANNE | — |
| 17801689 | APPLICATION OF DISULFIRAM IN CORONAVIRUS RESISTANCE | AGUIRRE, AMANDA L | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 2669 | 1 |
| 2146 | 1 |
| 1674 | 1 |
| 1637 | 1 |
| 1699 | 1 |
| 1635 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18840525 | NUCLEIC ACID CONSTRUCT BASED ON CRE-LOXP AND CRISPR AND USE THEREOF | SPENCER, ANDREA LYNNE MORRIS | — | §102§103§112 | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18689031 | PROTEIN DEGRADATION COMPOUND BASED ON NAMPT TARGET PROTEIN AND APPLICATION THEREOF | ENGLISH, CONNOR KENNEDY | 1625 | §112 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18418386 | NEURAL IMPLICIT FUNCTION FOR END-TO-END RECONSTRUCTION OF DYNAMIC CRYO-EM STRUCTURES | ISLAM, PROMOTTO TAJRIAN | 2669 | §112 | Non-Final OA | 35d | Pending | Jan 22, 2024 |
| 18387463 | HIGH-EFFICIENT QUANTIZATION METHOD FOR DEEP PROBABILISTIC NETWORK | ZENG, WENWEI | 2146 | §101§103 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18557232 | INTRAMUSCULAR COMPOSITIONS OF BOTULINUM NEUROTOXINS | KAUFMAN, CLAIRE M | 1674 | §102§103§112 | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18553729 | GENE THERAPY FOR TREATING BETA-HEMOGLOBINOPATHIES | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103§112DP | Non-Final OA | — | Pending | Oct 02, 2023 |
| 18067732 | Decontamination of Environmental Water Sources Using Living Engineered Biofilm Materials | UNDERDAHL, THANE E | 1699 | §103§112Other | Non-Final OA | 30d | Pending | Dec 19, 2022 |
| 17822418 | COMPOSITIONS AND METHODS FOR DETECTING NUCLEIC ACID-PROTEIN INTERACTIONS | KONOPKA, CATHERINE ANNE | 1635 | §103 | Final Rejection | — | Pending | Aug 25, 2022 |
| 17801689 | APPLICATION OF DISULFIRAM IN CORONAVIRUS RESISTANCE | AGUIRRE, AMANDA L | 1626 | §102§103 | Final Rejection | — | Pending | Aug 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial